/Investor DB

Dunamu & Partners — 2022 Investments

2 investments dated 2022 · listed companies and verified rows first · show all

AvoMD AI & Roboticsavomd.comin𝕏Dec 2022 · $10M

Avo is a clinical artificial intelligence platform designed to reduce clinician burnout and improve healthcare outcomes by helping doctors practice evidence-based medicine.

AI & Machine LearningDigital HealthHealthtechBrooklyn, US

Joongheum Park(Founder / Executive Chairman / CPO)inYair Saperstein(Founder / CEO)inLaurence Coman(Founder / COO)in

BoardOmar Njie(Director)

Co-investors500 GlobalAlleyCorpEpsilon Health InvestorsLas Olas Venture CapitalMana VenturesMedMountain Ventures+10 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Genome Insight

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.